Adam Carlson
Optometrist · Grand Rapids, MINPI 1124352687
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,828 of the $6,001 with a category attached, or 63.8%. 12 manufacturers reported payments, led by Biotissue Holdings Inc. at 54.0% of the total. Reporting peaked in 2022 at $3,165 and has fallen 89.4% since, to $334 in 2025. Among optometrist clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 77 payments — averaging $77.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$3K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$790
- Bausch & Lomb Americas Inc.$462
- AbbVie$390
- Aerie Pharmaceuticals, Inc.$267
- Johnson & Johnson Vision Care, Inc.$209
- plus $642 from 6 others
What the payments were for
- Travel & lodging$2,17336%
- Food & beverage$3,82864%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 21 | $3,243 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 15 | $790 |
| Bausch & Lomb Americas Inc. | 11 | $462 |
| AbbVie(2 entities) | 6 | $390 |
| Aerie Pharmaceuticals, Inc. | 3 | $267 |
| Johnson & Johnson Vision Care, Inc. | 8 | $209 |
| Novartis | 5 | $193 |
| Kala Pharmaceuticals, Inc. | 3 | $158 |
| Sun Pharmaceutical Industries Inc. | 2 | $133 |
| Amgen | 1 | $96 |
| Lombart Brothers, Inc. | 1 | $37 |
| Tarsus Pharmaceuticals, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prokera$2,527
- AmnioGraft$2,527
- INFUSE$353
- BIOTRUE ONE DAY$249
- Rhopressa$245
- Rocklatan$245
- LUMIGAN$125
- BIOTRUE$125
- ULTRA$125
- XIIDRA$125
- CEQUA$125
- VUITY$123
- EYSUVIS$121
- ULTRA MULTIFOCAL TORIC$110
- Acuvue$102
How this compares
$6,001 in reported general payments places this provider in the 95th percentile of 1,523 optometrist providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 25 | $558 |
| Timolol Maleate | 13 | $524 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Grand Rapids
- Jay CrankGrand Rapids$209K
- Philip VanderlugtGrand Rapids$12K
- Thomas DunningGrand Rapids$7K
- Jamie KuzniarBloomfield$473K
- Monica JohnsonbaughGrosse Pointe$393K
- Nicholas BrunsFlint$238K
- Jeffrey VaranelliWarren$204K
- Thomas RothAnn Arbor$98K
- Frances Poma NowinskiBloomfield Twp$91K
- Michael LipsonWalled Lake$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.